Treatment guidelines for bronchial asthma are based on clinical studies and experience to control the symptoms of asthma in order to achieve clinical control and prolong the survival cycle of patients. Pharmacological treatment is based on glucocorticoids and bronchodilators, which can be used to dilate the bronchi during acute exacerbations and inhaled glucocorticoids during chronic persistence, in addition to immunotherapy, and systemic hormone therapy for severe asthma. In addition, education and management of asthma patients are also important measures to improve the effectiveness and reduce recurrence and improve the quality of life of patients, so that the control rate of adults can reach 80% through long-term standardized treatment by adhering to medication and avoiding exposure to allergens in life.